Explant rates of electrical neuromodulation devices in 1177 patients in a single center over an 11-year period.

Introduction: The publication of explant rates has established risk factors and a definitive objective outcome of failure for spinal cord stimulation (SCS) treating neuropathic pain. We present a UK study analyzing explants of electrical neuromodulation devices for different conditions over 11 years in a single center specializing in neuromodulation.

Methods: A retrospective analysis was performed using a departmental database between 2008 and 2019.